Fair Isaac Corp (FICO) Drops 5.75% on January 21

Equities Staff  |

Fair Isaac Corp (FICO) was one of the Russell 2000's biggest losers for Thursday January 21 as the stock slid 5.75% to $80.35, a loss of $-4.9 per share. Starting at an opening price of $85.52 a share, the stock traded between $80.20 and $85.62 over the course of the trading day. Volume was 324,322 shares over 3,775 trades, against an average daily volume of 191,742 shares and a total float of 31.08 million.

The losses send Fair Isaac Corp down to a market cap of $2.5 billion. In the last year, Fair Isaac Corp has traded between $97.56 and $70.29, and its 50-day SMA is currently $91.01 and 200-day SMA is $89.47.

The stock has a P/E Ratio of 32.2.

Fair Isaac Corporation is a provider of analytic, software and data management products and services that enable businesses to automate, improve and connect decisions.

Fair Isaac Corp is based out of San Jose, CA and has some 2,803 employees. Its CEO is William J. Lansing.

For a complete fundamental analysis analysis of Fair Isaac Corp, check out Equities.com’s Stock Valuation Analysis report for FICO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Dr Oliver Krause Founder Untitled Inc Part 1

Matt Bird sits down with Dr Oliver Krause, Founder Untitled Inc, in part 1 of this 2 part interview at the World Economic Forum at Davos 2019

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…